Literature DB >> 24192846

Prevalence of masked hypertension and associated factors in normotensive healthcare workers.

Javier Sobrino1, Mónica Domenech, Miguel Camafort, Ernest Vinyoles, Antonio Coca.   

Abstract

BACKGROUND AND
OBJECTIVE: Evidence on the elevated cardiovascular risk associated with masked hypertension (MHT) is becoming stronger. Determining the prevalence of MHT in apparently healthy individuals may enable better risk stratification and management.
METHODS: This was a cross-sectional study of normotensive healthcare workers recruited from 52 hypertension units. We included individuals aged at least 18 years with no known history of hypertension and office blood pressure (BP) less than 140/90 mmHg. MHT was defined as mean daytime ambulatory BP of at least 135/85 mmHg.
RESULTS: Overall, 485 individuals (mean age 43.1 years, 55% women) were included. The prevalence of MHT was 23.9% [95% confidence interval (CI): 20.1-27.7]. The most prevalent associated cardiovascular risk factors in the total population were smoking (24.9%), dyslipidemia (16.4%), a family history of premature cardiovascular disease (15.9%), and obesity (7.4%). A total of 45.4% of individuals had a family history of hypertension. MHT was associated with male sex [odds ratio (OR) 1.722, 95% CI: 1.091-2.718] and prehypertension (OR 4.561, 95% CI: 2.880-7.222). In univariate analysis, the OR of the diagnosis of MHT increased by 2.3% per year of age.
CONCLUSION: The prevalence of MHT in normotensive healthcare workers in Spain is almost 25%. Therefore, 24-h ambulatory BP monitoring should be routine in occupational health checks in health workers, especially men.

Entities:  

Mesh:

Year:  2013        PMID: 24192846     DOI: 10.1097/MBP.0000000000000002

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  7 in total

1.  Prehypertension or masked hypertension-which is responsible for target-organ damage?

Authors:  Ying Chen; Yu-li Huang; Wei-yi Mai
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

2.  Predicted Atherosclerotic Cardiovascular Disease Risk and Masked Hypertension Among Blacks in the Jackson Heart Study.

Authors:  D Edmund Anstey; John N Booth; Marwah Abdalla; Tanya M Spruill; Yuan-I Min; Paul Muntner; Daichi Shimbo
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-07

3.  Sex differences in masked hypertension: the Coronary Artery Risk Development in Young Adults study.

Authors:  Daniel N Pugliese; John N Booth; Luqin Deng; D Edmund Anstey; Natalie A Bello; Byron C Jaeger; James M Shikany; Donald Lloyd-Jones; Cora E Lewis; Joseph E Schwartz; Paul Muntner; Daichi Shimbo
Journal:  J Hypertens       Date:  2019-12       Impact factor: 4.844

4.  Uncontrolled hypertension in older patients: markers and associated factors to masked and white-coat effect.

Authors:  Nereida Kc Lima; Julio C Moriguti; Eduardo Ferriolli
Journal:  J Geriatr Cardiol       Date:  2016-08       Impact factor: 3.327

5.  Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis.

Authors:  Auttakiat Karnjanapiboonwong; Thunyarat Anothaisintawee; Usa Chaikledkaew; Charungthai Dejthevaporn; John Attia; Ammarin Thakkinstian
Journal:  BMC Cardiovasc Disord       Date:  2020-11-23       Impact factor: 2.298

6.  Predicting Out-of-Office Blood Pressure in the Clinic (PROOF-BP): Derivation and Validation of a Tool to Improve the Accuracy of Blood Pressure Measurement in Clinical Practice.

Authors:  James P Sheppard; Richard Stevens; Paramjit Gill; Una Martin; Marshall Godwin; Janet Hanley; Carl Heneghan; F D Richard Hobbs; Jonathan Mant; Brian McKinstry; Martin Myers; David Nunan; Alison Ward; Bryan Williams; Richard J McManus
Journal:  Hypertension       Date:  2016-03-21       Impact factor: 10.190

7.  Prevalence of prehypertension and associated risk factors among Chinese adults from a large-scale multi-ethnic population survey.

Authors:  Tao Xu; Junting Liu; Guangjin Zhu; Junxiu Liu; Shaomei Han
Journal:  BMC Public Health       Date:  2016-08-11       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.